Pancreatic Cancer Research

ResearcherBaylor College of MedicineActive in the last 2 years

Nagireddy Putluri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4488-7400; OpenAlex author ID A5010768908. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 7

  1. Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-29548-4↗
  2. Exercise Modulates Microbial Metabolites and Induces Stromal Remodeling in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-5143↗
  3. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways. Co-author DOI 10.1093/carcin/bgae025↗
  4. Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. Co-author DOI 10.3390/ijms241914652↗
  5. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment. Co-author DOI 10.1158/2159-8290.cd-19-0297↗
  6. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Last author DOI 10.1158/1940-6207.capr-18-0201↗
  7. Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma. Co-author DOI 10.1371/journal.pone.0017177↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Subrata Sen · 4 shared papers, 2019–2026 · strength 0.68
  2. Anirban Maitra · 3 shared papers, 2020–2026 · strength 0.50
  3. Warapen Treekitkarnmongkol · 2 shared papers, 2023–2026 · strength 0.42
  4. Tsung-Hung Yao · 1 shared paper, 2026 · strength 0.24
  5. Seetharaman Balasenthil · 1 shared paper, 2026 · strength 0.24
  6. Ye Hu · 1 shared paper, 2026 · strength 0.24
  7. Suprateek Kundu · 1 shared paper, 2026 · strength 0.24
  8. Randall E. Brand · 1 shared paper, 2026 · strength 0.24
  9. Eugene Jon Koay · 1 shared paper, 2026 · strength 0.24
  10. Ann McNeill Killary · 1 shared paper, 2026 · strength 0.24
  11. Paul D. Lampe · 1 shared paper, 2026 · strength 0.24
  12. An Ngo‐Huang · 1 shared paper, 2026 · strength 0.20
  13. Nathan H. Parker · 1 shared paper, 2026 · strength 0.20
  14. Keri Schadler · 1 shared paper, 2026 · strength 0.20
  15. Matthew H. G. Katz · 1 shared paper, 2026 · strength 0.20
  16. Riccardo Ballarò · 1 shared paper, 2026 · strength 0.20
  17. Sumedha Pareek · 1 shared paper, 2026 · strength 0.20
  18. Maria Q. B. Petzel · 1 shared paper, 2026 · strength 0.20
  19. Robin D. Wright · 1 shared paper, 2026 · strength 0.20
  20. Laura R. Prakash · 1 shared paper, 2026 · strength 0.20
  21. Vidhi Chandra · 1 shared paper, 2026 · strength 0.20
  22. Florencia M. McAllister · 1 shared paper, 2026 · strength 0.20
  23. Anurag Purushothaman · 1 shared paper, 2023 · strength 0.18
  24. Nader N Hanna · 1 shared paper, 2024 · strength 0.18
  25. Jianjun Gao · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.